https://www.selleckchem.com/pr....oducts/trastuzumab-d
OBJECTIVES To evaluate the factors related to breast cancer (BC) recurrence as well as survival in women ≤40 years old. METHODS This is a retrospective medical record review of women aged ≤40 years diagnosed with BC stages I to III between January 2009 and June 2017 at King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia. Demographic data collected included patients' initial presentation (including age and date of diagnosis), imaging studies, tumor characteristics, type of surgery, systemic therapy (if any) rec